Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisaborole 2% vs Tacrolimus 0.1% + Excimer Light in Stable Non-segmental Facial Vitiligo
NCT07904910Phase 3Recruiting
- Sponsor
- Cairo University
- Start
- May 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
A Phase 3 trial of AN2728 ointment vehicle in Vitiligo, sponsored by Cairo University. Started May 2026; status: recruiting.
02
Drugs
AN2728 ointment vehicle
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07904910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07904910.